Literature DB >> 27974050

Neonatal milk supplementation in lambs has persistent effects on growth and metabolic function that differ by sex and gestational age.

Mary J Berry1, Anne L Jaquiery2, Mark H Oliver2, Jane E Harding3, Frank H Bloomfield2.   

Abstract

The perinatal environment has a major influence on long-term health and disease risk. Preterm birth alters early-life environment and is associated with altered metabolic function in adulthood. Whether preterm birth per se or the early nutritional interventions used to support growth in preterm infants underpins this association is unknown. Lambs born preterm, following dexamethasone induction of labour, or spontaneously at term were randomised to receive nutrient supplementation, analogous to the milk fortifier used clinically or water as a control for the first 2 weeks after birth. Thereafter, nutrition was not different between groups. Growth was monitored, and the glucose-insulin axis function was assessed in juvenile (4 months) and adult life (14 months). Early nutrition influenced adult metabolic function and body composition to a greater extent than preterm birth. In supplemented females, arginine-stimulated insulin secretion was increased in preterm but reduced in term-born juveniles compared with controls (repeated-measures ANOVA P<0·01). In supplemented preterm males, adult weight, ponderal index (PI) and fasting insulin concentrations were elevated compared with preterm controls (weight, 75 (sem 3) v. 69 (sem 2) kg; PI, 48·0 (sem 2·1) v. 43·7 (sem 1·7) kg/m3; fasting insulin, 0·19 (sem 0·02) v. 0·10 (sem 0·02) ng/ml). Conversely, supplemented term-born males had reduced adult weight, PI and fasting insulin concentrations compared with term-born controls (weight, 64 (sem 2) v. 70 (sem 2) kg; PI, 44·4 (sem 1·8) v. 48·2 (sem 1·7) kg/m3; fasting insulin, 0·09 (sem 0·02) v. 0·14 (sem 0·02) ng/ml; all group×supplement interactions P<0·05). Adult metabolic health may reflect both gestational age at birth and early nutrition. Human studies are urgently needed to investigate the adult sex-specific health implications of neonatal nutritional strategies.

Entities:  

Keywords:  CIDR controlled internal drug release; CRL crown–rump length; DO deuterium oxide; HGC hyperglycaemic clamps; IVGTT intravenous glucose tolerance test; PI; ponderal index; Developmental origins; Neonatal nutrition; Preterm birth; Sex differences

Mesh:

Substances:

Year:  2016        PMID: 27974050     DOI: 10.1017/S0007114516004013

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  5 in total

1.  Impact of macronutrient supplements on later growth of children born preterm or small for gestational age: A systematic review and meta-analysis of randomised and quasirandomised controlled trials.

Authors:  Luling Lin; Emma Amissah; Gregory D Gamble; Caroline A Crowther; Jane E Harding
Journal:  PLoS Med       Date:  2020-05-26       Impact factor: 11.069

2.  Macronutrient Supplements in Preterm and Small-for-Gestational-Age Animals: A Systematic Review and Meta-analysis.

Authors:  Emma Amissah; Luling Lin; Gregory D Gamble; Caroline A Crowther; Frank H Bloomfield; Jane E Harding
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

3.  The microbial biogeography of the gastrointestinal tract of preterm and term lambs.

Authors:  Clara Yieh Lin Chong; Tommi Vatanen; Mark Oliver; Frank H Bloomfield; Justin M O'Sullivan
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

4.  Perinatal complications and maximising lamb survival in an adolescent paradigm characterised by premature delivery and low birthweight.

Authors:  Jacqueline M Wallace; Paul O Shepherd; John S Milne; Raymond P Aitken
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

5.  Impact of macronutrient supplements for children born preterm or small for gestational age on developmental and metabolic outcomes: A systematic review and meta-analysis.

Authors:  Luling Lin; Emma Amissah; Gregory D Gamble; Caroline A Crowther; Jane E Harding
Journal:  PLoS Med       Date:  2019-10-30       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.